Single high-dose radiation vs standard palliative radiation
Part of Cancer clinical trials.
This Phase 2 study compares a one-time, high-dose radiation treatment (SBRT) with the usual, shorter-course palliative radiation. The goal is to see which approach better relieves symptoms from metastatic (spread) cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed cancer diagnosis and evidence it has spread to other parts of the body
- You have a cancer spot that is causing symptoms, or will likely cause symptoms soon, where radiation could help for relief or prevention
- You can attend required check-ins and complete pre- and post-treatment questionnaires and assessments
- If you could become pregnant, you must use reliable birth control during the study; you must also let your doctor know right away if pregnancy is possible
- You have not had prior radiation to the exact same area that this study would treat
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a focused, high-precision type of radiation can control many cancer spread-out spots (“metastases”) at the same time, while keeping side effects acceptable. It may help people with many metastases live longer or have better disease control by aiming treatment at every treatable spot.
This trial tests whether high-precision radiation (SBRT) can improve outcomes for people with up to 5 small, stable metastases from certain cancers, compared to usual palliative care. It is for those whose disease is not growing after current chemotherapy.
This Phase 2 study tests whether a stronger (higher-dose) radiation plan can better reduce pain from tumors that have spread to bone or other areas. It’s meant to help people live more comfortably by targeting painful spots while avoiding certain high-risk situations.
This trial compares two types of radiation therapy to relieve pain from cancer that has spread to the bones. It aims to see whether a more targeted, high-dose approach (SBRT) works better than standard palliative radiation.
This trial tests a higher dose of radiation to shrink large tumors and relieve pain in people with advanced cancer. It aims to improve quality of life by targeting up to three large tumors with a single treatment.
This trial compares two types of radiation therapy—standard palliative radiation and a more targeted high-dose treatment (SBRT)—to see which better relieves pain from bone metastases that have spread outside the spine. It is for people with solid tumors who have a painful bone spot and are expected to live at least 6 months.
Hear when a new Metastatic Malignant Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.